May 11, 2018 / 6:05 AM / 4 months ago

BRIEF-Bayer Receives Approval For Eylea In China

May 11 (Reuters) - Bayer AG:

* SAYS RECEIVES APPROVAL FOR EYLEA IN CHINA

* EYLEA GAINS APPROVAL IN CHINA FOR TREATMENT OF VISUAL IMPAIRMENT DUE TO NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below